Our stock screening tool has pinpointed CBRE GROUP INC - A (NYSE:CBRE) as a growth stock that isn't overvalued. NYSE:CBRE is excelling in various growth indicators while maintaining a solid financial footing. Furthermore, it remains attractively priced. Let's delve into the specifics below.
Growth Analysis for NYSE:CBRE
ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NYSE:CBRE, the assigned 7 reflects its growth potential:
- The Earnings Per Share has grown by an nice 10.03% over the past year.
- CBRE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.00%.
- Measured over the past years, CBRE shows a quite strong growth in Revenue. The Revenue has been growing by 8.41% on average per year.
- CBRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.71% yearly.
- CBRE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.98% yearly.
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Valuation Assessment of NYSE:CBRE
ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NYSE:CBRE has earned a 5 for valuation:
- Based on the Price/Earnings ratio, CBRE is valued a bit cheaper than 75.00% of the companies in the same industry.
- CBRE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 79.69% of the companies in the same industry.
- Based on the Enterprise Value to EBITDA ratio, CBRE is valued a bit cheaper than 75.00% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, CBRE is valued a bit cheaper than 73.44% of the companies in the same industry.
- The decent profitability rating of CBRE may justify a higher PE ratio.
- CBRE's earnings are expected to grow with 22.73% in the coming years. This may justify a more expensive valuation.
Health Analysis for NYSE:CBRE
ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. NYSE:CBRE was assigned a score of 5 for health:
- An Altman-Z score of 3.72 indicates that CBRE is not in any danger for bankruptcy at the moment.
- With a decent Altman-Z score value of 3.72, CBRE is doing good in the industry, outperforming 79.69% of the companies in the same industry.
- Looking at the Debt to FCF ratio, with a value of 6.08, CBRE belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
What does the Profitability looks like for NYSE:CBRE
ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NYSE:CBRE, the assigned 6 is a significant indicator of profitability:
- CBRE's Return On Assets of 3.86% is amongst the best of the industry. CBRE outperforms 87.50% of its industry peers.
- The Return On Equity of CBRE (11.02%) is better than 89.06% of its industry peers.
- The Return On Invested Capital of CBRE (6.88%) is better than 93.75% of its industry peers.
- CBRE had an Average Return On Invested Capital over the past 3 years of 7.76%. This is above the industry average of 4.83%.
- Looking at the Profit Margin, with a value of 2.79%, CBRE is in the better half of the industry, outperforming 73.44% of the companies in the same industry.
- CBRE has a better Operating Margin (4.23%) than 68.75% of its industry peers.
Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.
For an up to date full fundamental analysis you can check the fundamental report of CBRE
Disclaimer
This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.